METHODS OF TREATING KRAS MUTATION SUBTYPES WITH CD40 AGONIST

The present disclosure provides methods of treating cancer with a specific KRAS mutation subtype with a combination treatment with a CD40 agonist and one or more chemotherapy drugs. La présente invention concerne des procédés de traitement du cancer avec un sous-type de mutation KRAS spécifique avec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LAVALLEE, Theresa, MCDANIEL, Lee Davis, KITCH, Lacey
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	LAVALLEE, Theresa MCDANIEL, Lee Davis KITCH, Lacey
description	The present disclosure provides methods of treating cancer with a specific KRAS mutation subtype with a combination treatment with a CD40 agonist and one or more chemotherapy drugs. La présente invention concerne des procédés de traitement du cancer avec un sous-type de mutation KRAS spécifique avec une polythérapie avec un agoniste CD40 et un ou plusieurs médicaments de chimiothérapie.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022266496A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022266496A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022266496A13</originalsourceid><addsrcrecordid>eNrjZLDxdQ3x8HcJVvB3UwgJcnUM8fRzV_AOcgxW8A0NAfL8_RSCQ51CIgNcgxXCPUM8FJxdTAwUHN39_TyDQ3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkZGRmZmJpZmjoTFxqgCuGSqF</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS OF TREATING KRAS MUTATION SUBTYPES WITH CD40 AGONIST</title><source>esp@cenet</source><creator>LAVALLEE, Theresa ; MCDANIEL, Lee Davis ; KITCH, Lacey</creator><creatorcontrib>LAVALLEE, Theresa ; MCDANIEL, Lee Davis ; KITCH, Lacey</creatorcontrib><description>The present disclosure provides methods of treating cancer with a specific KRAS mutation subtype with a combination treatment with a CD40 agonist and one or more chemotherapy drugs. La présente invention concerne des procédés de traitement du cancer avec un sous-type de mutation KRAS spécifique avec une polythérapie avec un agoniste CD40 et un ou plusieurs médicaments de chimiothérapie.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221222&DB=EPODOC&CC=WO&NR=2022266496A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221222&DB=EPODOC&CC=WO&NR=2022266496A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAVALLEE, Theresa</creatorcontrib><creatorcontrib>MCDANIEL, Lee Davis</creatorcontrib><creatorcontrib>KITCH, Lacey</creatorcontrib><title>METHODS OF TREATING KRAS MUTATION SUBTYPES WITH CD40 AGONIST</title><description>The present disclosure provides methods of treating cancer with a specific KRAS mutation subtype with a combination treatment with a CD40 agonist and one or more chemotherapy drugs. La présente invention concerne des procédés de traitement du cancer avec un sous-type de mutation KRAS spécifique avec une polythérapie avec un agoniste CD40 et un ou plusieurs médicaments de chimiothérapie.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDxdQ3x8HcJVvB3UwgJcnUM8fRzV_AOcgxW8A0NAfL8_RSCQ51CIgNcgxXCPUM8FJxdTAwUHN39_TyDQ3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXy4v5GBkZGRmZmJpZmjoTFxqgCuGSqF</recordid><startdate>20221222</startdate><enddate>20221222</enddate><creator>LAVALLEE, Theresa</creator><creator>MCDANIEL, Lee Davis</creator><creator>KITCH, Lacey</creator><scope>EVB</scope></search><sort><creationdate>20221222</creationdate><title>METHODS OF TREATING KRAS MUTATION SUBTYPES WITH CD40 AGONIST</title><author>LAVALLEE, Theresa ; MCDANIEL, Lee Davis ; KITCH, Lacey</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022266496A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LAVALLEE, Theresa</creatorcontrib><creatorcontrib>MCDANIEL, Lee Davis</creatorcontrib><creatorcontrib>KITCH, Lacey</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAVALLEE, Theresa</au><au>MCDANIEL, Lee Davis</au><au>KITCH, Lacey</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS OF TREATING KRAS MUTATION SUBTYPES WITH CD40 AGONIST</title><date>2022-12-22</date><risdate>2022</risdate><abstract>The present disclosure provides methods of treating cancer with a specific KRAS mutation subtype with a combination treatment with a CD40 agonist and one or more chemotherapy drugs. La présente invention concerne des procédés de traitement du cancer avec un sous-type de mutation KRAS spécifique avec une polythérapie avec un agoniste CD40 et un ou plusieurs médicaments de chimiothérapie.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_WO2022266496A1
source	esp@cenet
subjects	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS TESTING VINEGAR WINE
title	METHODS OF TREATING KRAS MUTATION SUBTYPES WITH CD40 AGONIST
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T04%3A54%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAVALLEE,%20Theresa&rft.date=2022-12-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022266496A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true